Table 3. Clinicopathological and radiological variables correlation with upgrade for pure LN cases.
| Variables | Upgrade | P-value | |
|---|---|---|---|
|
| |||
| Yes (n = 11) | No (n = 23) | ||
| Age (mean and range) | |||
| 52 (41,77) years | 51 (41,72) years | 52 (41,77) years | NS |
| Race | |||
| African American (n = 1) | 0 (0) | 1 (4) | NS |
| Caucasian (n = 33) | 11 (100) | 22 (96) | |
| Menopause status | |||
| Post (n = 13)a | 4 (36) | 9 (39) | NS |
| Pre (n = 19) | 7 (64) | 12 (52) | |
| Mass vs non-mass | |||
| Mass (n = 12) | 2 (18) | 10 (44) | NS |
| Non-mass (n = 22) | 9 (82) | 13 (57) | |
| Reason for MRI | |||
| BIRAD 3 (n = 4) | 1 (9) | 3 (13) | NS |
| Clinical (n = 11) | 4 (36) | 7 (30) | |
| High risk (n = 18) | 6 (55) | 12 (52) | |
| Staging (n = 1) | 0 (0) | 1 (4.3) | |
| ILC vs IC-NST or DCIS | |||
| IC-NST or DCIS (n = 16) | 4 (36) | 12 (52) | NS |
| ILC (n = 7) | 3 (27) | 4 (17) | |
| Concurrent vs past | |||
| Concurrent (n = 18) | 5 (46) | 13 (57) | NS |
| Past (n = 5) | 2 (18) | 3 (13) | |
| Ipsilateral vs contralateral | |||
| Contralateral (n = 12) | 1 (9) | 11 (48) | 0.03 |
| Ipsilateral (n = 11) | 6 (55) | 5 (22) | |
Abbreviations: DCIS, ductal carcinoma in situ; IC-NST, invasive carcinoma of no special type; ILC, invasive lobular carcinoma; LN, lobular neoplasia; MRI, magnetic resonance imaging; NS, not significant.
a
Two patients were perimenopausal.